ReviewArchives of toxicology2025
Insights into the molecular mechanism of neurological diseases and their pathophysiological responses.
Review in Archives of toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The origin of neurological disorders and their associated symptoms have been known for a very long time tracing to the origin of human being. However, the detailed mechanism at the molecular level came to existence after intensive research for decades. This review aims to discuss the molecular mechanisms responsible for the onset till the progression of these diseases casting its role at cellular, organelles, and metal ions level. Advanced microscopic techniques enabled correlation of pathological responses at ultrastructural level that is helpful if coupled with biochemical parameters. The review also sheds a glimpse of focus on creative movements to improve cognition in neurodegenerative patients as a part of therapy.
Indexed as
Identifiers
40944735What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.